Imodium COMBO 2 mg/125 mg tablete
| Name | Imodium COMBO 2 mg/125 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-849757099 |
| Active Substance | loperamidklorid simetikon |
| Composition | jedna tableta sadrži 2 mg loperamidklorida i 125 mg dimetikona kao simetikon |
| Pharmaceutical Form | tableta |
| Manufacturer | Janssen-Cilag S.p.A., Borgo San Michele, Latina, Italija |
| Marketing Authorisation Holder | McNeil Healthcare (Ireland) Limited, Tallaght, High Street, Office 5, 6 & 7, Block 5, Dublin, Irska |
| Marketing Authorisation Date | 19.01.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/398 |
| Registration Number | 381-12-01/70-24-22 |
| Prescription | bez recepta |
| Distribution | u ljekarni |
| Advertising to general public | dopušteno |
| ATC Code | A07DA53 |
| Medicinal product marketed in the Croatia | Ne |
| SmPC | download |
| PL | download |
